This work was partially supported by the Research Council of Norway through its Centers of Excellence scheme, project number 332727, and its Proof-of-Concept Research commercialization program, project number 333902, as well as by the Novo Nordisk Foundation Pioneer Innovator Grant 0090894
Prolonged systemic hyperglycemia does not cause pericyte loss and permeability at the mouse blood-brain barrier
5-Amino-1MQ has been investigated in preclinical research in relation to nicotinamide N-methyltransferase (NNMT) inhibition and associated cellular pathways
Torres-Velarde JM, Allen KN, Salvador-Pascual A, Leija RG, Luong D, Moreno-Santilln DD, et al
Even though the location of major pathology differs (mainly spinal cord in EAE vs